North America Hyperpigmentation Disorder Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)

No. of Pages: 84    |    Report Code: BMIRE00030848    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Hyperpigmentation Disorder Treatment Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Hyperpigmentation Disorder Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Hyperpigmentation Disorder Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rise in Prevalence of Melasma
  • 5.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
5.2 Market Opportunities
  • 5.2.1 Strategic Initiatives by Market Players
5.3 Future Trends
  • 5.3.1 Use of Ablative Lasers
  • 5.3.2 Novel Products Based on PATH-3 Technology
5.4 Impact of Drivers and Restraints

6. North America Hyperpigmentation Disorder Treatment Market Regional Analysis

6.1 North America Hyperpigmentation Disorder Treatment Market Overview
6.2 North America Hyperpigmentation Disorder Treatment Market Revenue 2020-2030 (US$ Million)
6.3 North America Hyperpigmentation Disorder Treatment Market Forecast Analysis

7. North America Hyperpigmentation Disorder Treatment Market Analysis – by Treatment Type

7.1 Cosmeceutical
  • 7.1.1 Overview
  • 7.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Light or Laser Therapy
  • 7.2.1 Overview
  • 7.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Microdermabrasion
  • 7.3.1 Overview
  • 7.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Chemical Peels
  • 7.4.1 Overview
  • 7.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cryotherapy
  • 7.5.1 Overview
  • 7.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Hyperpigmentation Disorder Treatment Market Analysis – by Condition

8.1 Melasma
  • 8.1.1 Overview
  • 8.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Solar Lentigines
  • 8.2.1 Overview
  • 8.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Post-inflammatory Hyperpigmentation
  • 8.3.1 Overview
  • 8.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Hyperpigmentation Disorder Treatment Market – North America Analysis

9.1 North America
  • 9.1.1 North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 9.1.1.1 North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 US: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.1.1 US: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    • 9.1.1.1.2 US: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
  • 9.1.1.2 Canada: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.2.1 Canada: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    • 9.1.1.2.2 Canada: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
  • 9.1.1.3 Mexico : North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 9.1.1.3.1 Mexico : North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    • 9.1.1.3.2 Mexico : North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. North America Hyperpigmentation Disorder Treatment Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 AbbVie Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Bayer AG
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Galderma SA
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 L'OREAL S.A.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Lutronic Co Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Obagi Cosmeceuticals LLC
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Vivier Pharma Inc
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Pierre Fabre Group
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - N Market

  1. AbbVie Inc
  2. Bayer AG
  3. Galderma SA
  4. L'OREAL S.A.
  5. Lutronic Co Ltd
  6. Obagi Cosmeceuticals LLC
  7. Vivier Pharma Inc
  8. Pierre Fabre Group